Berndsen, R.H.; Swier, N.; van Beijnum, J.R.; Nowak-Sliwinska, P.
Colorectal Cancer Growth Retardation through Induction of Apoptosis, Using an Optimized Synergistic Cocktail of Axitinib, Erlotinib, and Dasatinib. Cancers 2019, 11, 1878.
https://doi.org/10.3390/cancers11121878
AMA Style
Berndsen RH, Swier N, van Beijnum JR, Nowak-Sliwinska P.
Colorectal Cancer Growth Retardation through Induction of Apoptosis, Using an Optimized Synergistic Cocktail of Axitinib, Erlotinib, and Dasatinib. Cancers. 2019; 11(12):1878.
https://doi.org/10.3390/cancers11121878
Chicago/Turabian Style
Berndsen, Robert H., Nathalie Swier, Judy R. van Beijnum, and Patrycja Nowak-Sliwinska.
2019. "Colorectal Cancer Growth Retardation through Induction of Apoptosis, Using an Optimized Synergistic Cocktail of Axitinib, Erlotinib, and Dasatinib" Cancers 11, no. 12: 1878.
https://doi.org/10.3390/cancers11121878
APA Style
Berndsen, R. H., Swier, N., van Beijnum, J. R., & Nowak-Sliwinska, P.
(2019). Colorectal Cancer Growth Retardation through Induction of Apoptosis, Using an Optimized Synergistic Cocktail of Axitinib, Erlotinib, and Dasatinib. Cancers, 11(12), 1878.
https://doi.org/10.3390/cancers11121878